So we stay at an impasse. Persons will go on to consider medicines—blindly, Generally—and several will subsequently operate the potential risk of overdose and Loss of life. But In case the authorities received’t offer data and instruments for hurt minimisation, we will. MAPS’ open-label MDMA study recently started in Europe. https://englandk554aqg2.tnpwiki.com/user